Advertisement

Validation of Coronavirus E Proteins Ion Channels as Targets for Antiviral Drugs

  • Lauren Wilson
  • Peter Gage
  • Gary Ewart
Conference paper
  • 1k Downloads
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 581)

Keywords

Human Immunodeficiency Virus Type Severe Acute Respiratory Syndrome Infectious Bronchitis Virus Selectivity Index Severe Acute Respiratory Syndrome 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    S. Siddell, in: The Coronaviridae, edited by S. G. Siddell (Plenum Press, New York, 1995), pp. 181-189.Google Scholar
  2. 2.
    X. Shen, et al. , Small envelope protein E of SARS: Cloning, expression, purification, CD determination, and bioinformatics analysis, Acta Pharmacol. Sin. 24, 505-511 (2003).Google Scholar
  3. 3.
    W. B. Fischer and M. S. Sansom, Viral ion channels: Structure and function, Biochim. Biophys. Acta 1561, 27-45 (2002).CrossRefPubMedGoogle Scholar
  4. 4.
    M. E. Gonzalez and L. Carrasco, Viroporins, FEBS Lett. 552, 28-34 (2003).CrossRefPubMedGoogle Scholar
  5. 5.
    Y. Tang, P. Venkataraman, J. Knopman, R. A. Lamb, and L. H. Pinto, in: Viral Membrane Proteins: Structure, Function, and Drug Design, edited by W. B. Fisher, 9 (Kluwer Academic / Plenum Publishers, New York, Boston, Dordrecht, London, Moscow, 2005).Google Scholar
  6. 6.
    P. W. Gage, G. Ewart, J. Melton, and A. Premkumar, in: Viral Membrane Proteins: Structure, Function, and Drug Design, edited by W. B. Fisher, 21 (Kluwer Academic / Plenum Publishers, New York, Boston, Dordrecht, London, Moscow, 2005).Google Scholar
  7. 7.
    U. Schubert, et al. , The two biological activities of human immunodeficiency virus type 1 vpu protein involve two separable structural domains, J. Virol. 70, 809-819 (1996).PubMedGoogle Scholar
  8. 8.
    A. Premkumar, L. Wilson, G. D. Ewart, and P. W. Gage, Cation-selective ion channels formed by p7 of hepatitis C virus are blocked by hexamethylene amiloride, FEBS Lett. 557, 99-103 (2004).CrossRefPubMedGoogle Scholar
  9. 9.
    S. D. Griffin, et al. , The p7 protein of hepatitis C virus forms an ion channel that is blocked by the antiviral drug, amantadine, FEBS Lett. 535, 34-38 (2003).CrossRefPubMedGoogle Scholar
  10. 10.
    D. Pavlovic, et al. , The hepatitis C virus p7 protein forms an ion channel that is inhibited by long-alkyl-chain iminosugar derivatives, Proc. Natl. Acad. Sci. USA 100, 6104-6108 (2003).CrossRefPubMedGoogle Scholar
  11. 11.
    L. H. Pinto, L. J. Holsinger, and R. A. Lamb, Influenza virus M2 protein has ion channel activity, Cell 69, 517-528 (1992).CrossRefPubMedGoogle Scholar
  12. 12.
    D. M. Fleming, Managing influenza: Amantadine, rimantadine and beyond, Int. J. Clin. Pract. 55, 189-195 (2001).PubMedGoogle Scholar
  13. 13.
    L. Wilson, C. McKinlay, P. Gage, and G. Ewart, SARS coronavirus E protein forms cation-selective ion channels, Virology 330, 322-331 (2004).CrossRefPubMedGoogle Scholar
  14. 14.
    L. Wilson, P. Gage, and G. Ewart, Hexamethylene amiloride blocks E protein ion channels and inhibits coronavirus replication (submitted).Google Scholar
  15. 15.
    J. Ortego, D. Escors, H. Laude, and L. Enjuanes, Generation of a replication-competent, propagation-deficient virus vector based on the transmissible gastroenteritis coronavirus genome, J. Virol. 76, 11518-11529 (2002).CrossRefPubMedGoogle Scholar
  16. 16.
    M. E. Gonzalez and L. Carrasco, Human immunodeficiency virus type 1 vpu protein affects Sindbis virus glycoprotein processing and enhances membrane permeabilization, Virology 279, 201-209 (2001).CrossRefPubMedGoogle Scholar
  17. 17.
    P. S. Masters, et al. , 2005, Genetic and molecular biological analysis of protein-protein interactions in coronavirus assembly. in Xth International Nidovirus Symposium: Towards Control of SARS and Other Nidovirus Diseases (eds. Holmes, K. V. & Perlman, S. ) (Cheyenne Mountain Resort, Colorado Springs, CO).Google Scholar
  18. 18.
    U. Schubert, et al. , Identification of an ion channel activity of the vpu transmembrane domain and its involvement in the regulation of virus release from HIV-1-infected cells, FEBS Lett. 398, 12-18 (1996).CrossRefPubMedGoogle Scholar
  19. 19.
    K. C. Duff, and R. H. Ashley, The transmembrane domain of influenza a M2 protein forms amantadine-sensitive proton channels in planar lipid bilayers, Virology 190, 485-489 (1992).CrossRefPubMedGoogle Scholar
  20. 20.
    C. E. Machamer, and Y. Soonjeon, 2006, The transmembrane domain of the infectious bronchitis virus E protein is required for efficient virus release, this volume, pages 193-198.Google Scholar
  21. 21.
    Y. Ye, and B. G. Hogue, Role of the mouse hepatitis coronavirus envelope protein transmembrane domain, this volume pages 187-192.Google Scholar
  22. 22.
    L. Kuo, and P. S. Masters, The small envelope protein E is not essential for murine coronavirus replication, J. Virol. 77, 4597-4608 (2003).CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2006

Authors and Affiliations

  • Lauren Wilson
    • 1
  • Peter Gage
    • 2
  • Gary Ewart
    • 3
  1. 1.ANU Medical SchoolAustralia
  2. 2.JCSMRANUAustralia
  3. 3.Biotron Ltd.Australia

Personalised recommendations